Newsroom | 1879 results
Sorted by: Latest
-
Crux Collaborates with Novo Nordisk to Offer Access to Wegovy® and Other Obesity Management Medications
MCLEAN, Va.--(BUSINESS WIRE)--Crux, a benefits operating system that connects employers, pharmaceutical manufacturers, and benefit solution providers, today announced a collaboration with global healthcare company Novo Nordisk to expand affordable and simplified access to authentic anti-obesity medications (AOMs) like Wegovy® for employer health plans across the United States. Through an alternative pharmacy benefit structure, the agreement will allow Crux to deliver a dedicated carve-out solut...
-
Kirin and Blackmores Team Up to Release Cognitive Function Support Supplements in Australia and New Zealand Formulated with Kirin Group’s Cognizin® Citicoline
TOKYO--(BUSINESS WIRE)--Kirin Holdings Company, Limited (Kirin Holdings)(TOKYO:2503) and Blackmores Limited (Blackmores), Kirin’s group company and Australia's leading natural health company, are proud to announce the launch of Blackmores Cognition Ultra in Australia and Blackmores Ultra Brain Care in New Zealand. This new supplement is formulated with Cognizin® Citicoline, a scientifically supported ingredient from Kyowa Hakko Bio Co., Ltd., a Kirin Group company, and is Blackmores’ first prod...
-
Biote Schedules Second Quarter 2026 Financial Results Release and Conference Call
IRVING, Texas--(BUSINESS WIRE)--biote Corp. (Nasdaq: BTMD) (“Biote” or the “Company”), a leader in innovative hormone optimization and healthy aging solutions that advance the healthspan of our Practitioners’ patients, today announced the Company will provide second quarter financial results on Wednesday, August 5, 2026, after the close of the market. A conference call to discuss the firm’s results will be held at 5:00 p.m. ET the same day. Conference Call Details The conference call may be acc...
-
ClostraBio Announces Positive Results in Landmark Clinical Study with Next-Generation Probiotic CLB101™ and NutraIngredients USA 2026 Award
CHICAGO--(BUSINESS WIRE)--ClostraBio, a biotechnology company developing next-generation probiotics to support gut health, today announced the completion of the first randomized, double-blind, placebo-controlled human clinical study evaluating its next-generation probiotic strain, Anaerostipes caccae CLB101™. The study achieved both the primary safety and tolerability endpoint while also demonstrating statistically significant differences in key secondary efficacy endpoints. The clinical study...
-
Starco Brands Announces Acquisition of Custom Bakehouse
LOS ANGELES--(BUSINESS WIRE)--Starco Brands, Inc. (the “Company” or “Starco”) (OTCQB: STCB) announced today that it completed the acquisition of Custom Bakehouse on July 15, 2026, a highly strategic transaction that advances its long-term vision of building a fully integrated consumer products platform by strengthening the Company’s manufacturing capabilities and brand portfolio. The acquisition expands Starco's capabilities across powdered foods, nutritional blends, drink and hydration mixes,...
-
21st Century Healthcare Appoints Katie Doyle to Board of Directors
TEMPE, Ariz.--(BUSINESS WIRE)--21st Century Healthcare, Inc. ("21st Century" or the "Company"), a leading manufacturer of vitamins, minerals, and supplements, and a portfolio company of Grant Avenue Capital LLC ("Grant Avenue"), a healthcare-focused, middle-market private equity firm, today announced the appointment of Katie Doyle to its Board of Directors. Ms. Doyle brings over 30 years of experience leading and advising consumer health and wellness companies. She most recently served as Execu...
-
Medifast to Announce Financial Results for the Second Quarter Ended June 30, 2026
BALTIMORE--(BUSINESS WIRE)--Medifast (NYSE: MED), the metabolic health and wellness company known for its science-backed comprehensive metabolic health system, Trilivy, will announce financial results for the quarter ended June 30, 2026 on Monday, August 3, 2026, after market close. The Company will host a conference call to discuss the results with additional comments and details. Company participants will be Nick Johnson, Chief Executive Officer, and Jim Maloney, Chief Financial Officer. The...
-
Herbalife CFO to Participate in Maxim Group “Health, Wellness & Longevity” Virtual Conference on July 22
LOS ANGELES--(BUSINESS WIRE)--Herbalife Ltd. (NYSE: HLF), a premier health and wellness company, community and platform, today announced John DeSimone, Chief Financial Officer, will participate in a fireside chat at the “Health, Wellness & Longevity” Virtual Conference presented by Maxim Group LLC on Wednesday, July 22, 2026 at 2:00 p.m. ET (11:00 a.m. PT). The live webcast will be available at the following link: https://digital.maximgrp.com/events/health-wellness-longevity-07222026 A link...
-
Hims & Hers Chief Accounting Officer, Irene Becklund, Announces Departure from the Company
SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (NYSE: HIMS), the leading health and wellness platform, today announced its Chief Accounting Officer, Irene Becklund will depart the company after more than seven years, effective October 9, 2026. Becklund will then serve as an advisor to the company for several months to assist with the transition. The company will conduct a search for her permanent successor, with Yemi Okupe, CFO of Hims & Hers, assuming the responsibilities of...
-
Medifast® Enters a New Era: Introducing Trilivy™, a Science-Backed Metabolic Health System
BALTIMORE--(BUSINESS WIRE)--Medifast, Inc. (NYSE: MED) today announced the launch of Trilivy, a comprehensive metabolic health system uniquely designed to support healthy lifestyle change. The launch also introduces newly formulated meal replacements, including the Trilivy Reset Fueling line enhanced with MetaVantage Technology™, a platform of proprietary ingredient formulas intended to optimize metabolism by unlocking key metabolic pathways. The launch of Trilivy marks a major corporate transf...